Answers are grounded in this paper and cite their sources.
Explores the role of clonotypic B cells in plasma-cell neoplasia, suggesting caution in detecting disease progression.
Clonotypic B cells have been proposed as a potential disease reservoir in multiple myeloma and light-chain amyloidosis, but Gonzalez and colleagues demonstrate that they do not necessarily share the malignant potential of disease clones. Their study shows that the key genetic hallmarks of disease are largely restricted to the plasma-cell compartment and raises caution that assays detecting minimal residual disease may yield false-positive results by detecting rare clonotypic B cells. See related article by Gonzalez et al., p. XX .
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: